lovastatin has been researched along with Granulocytic Leukemia, Chronic, Stable Phase in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Basak, GW; Glodkowska-Mrowka, E; Jakobisiak, M; Mrowka, P; Niesiobedzka-Krezel, J; Seferynska, I; Stoklosa, T; Wlodarski, PK | 1 |
1 other study(ies) available for lovastatin and Granulocytic Leukemia, Chronic, Stable Phase
| Article | Year |
|---|---|
Statins inhibit ABCB1 and ABCG2 drug transporter activity in chronic myeloid leukemia cells and potentiate antileukemic effects of imatinib.
Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP Binding Cassette Transporter, Subfamily G, Member 2; ATP-Binding Cassette Transporters; Benzamides; Blotting, Western; Cell Line; Cell Survival; Drug Synergism; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Imatinib Mesylate; K562 Cells; Leukemia, Myeloid, Chronic-Phase; Lovastatin; Mice; Neoplasm Proteins; Piperazines; Pyrimidines | 2014 |